http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-200424312-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a5acc73c34cf2b348b8bce69d72b9c37 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 |
| filingDate | 2004-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a1191e9475cdc168d13bcbb45b9473a |
| publicationDate | 2004-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | TW-200424312-A |
| titleOfInvention | Dendritic cell for sieving medicine for anti-C-type hepatitis virus infection |
| abstract | The present invention provides a dendritic cell for sieving a medicine for anti-C-type hepatitis virus infection, which particularly uses a Sip-L-expressing cell for continuously infecting and propagating C-type hepatitis virus and generating an adapted mutant virus. Using such an adapted mutant HCV virus as an infection source, the Sip-L expressing cells can be used for novel anti-HCV drug screening. |
| priorityDate | 2004-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 65.